Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:1106-1113

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernhall, B.
Right arrow Articles by Kessler, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernhall, B.
Right arrow Articles by Kessler, C. M.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:1106-1113.)
© 1997 American Heart Association, Inc.


Articles

Fibrinolytic Activity Is Similar in Physically Active Men With and Without a History of Myocardial Infarction

Bo Fernhall; Linda M. Szymanski; Patrick A. Gorman; James Milani; Donald C. Paup; ; Craig M. Kessler

From the Exercise Science Programs (B.F., J.M., D.C.P.) and the Divisions of Hematology-Oncology (L.M.S., C.M.K.) and Cardiology (P.A.G.), The George Washington University Medical Center, Washington, DC.

Abstract The purpose of this study was to evaluate fibrinolytic potential at rest and after a fibrinolytic stressor in men with a history of myocardial infarction (MI) compared with an age- and activity-matched group of men without coronary artery disease (CAD). All men were currently enrolled in exercise programs. Tissue-type plasminogen activator (TPA) and plasminogen activator inhibitor 1 (PAI-1) activity and antigen levels were measured at rest and after a maximal exercise test. A 2x2 (groupxtime) ANOVA with repeated measures was used to evaluate fibrinolytic potential. Bivariate regressions were conducted to evaluate relations between fibrinolytic potential and maximal oxygen uptake (O2max). Age was similar between groups (CAD, 57.5±6.6; non-CAD, 58.1±7.3 years); however, O2max was higher in non-CAD subjects (36.2±6.2 vs 27.5±5.9 mL·kg-1·min-1). Mean±SEM resting TPA and PAI-1 activities were similar between CAD and non-CAD subjects (TPA, 2.8±0.2 vs 2.8±0.2 IU/mL; PAI-1, 15.9±3.1 vs 13.1±4.1 AU/mL). Both groups showed similar significant increases in TPA activity with exercise (P<.05), and postexercise TPA activity was also similar (CAD, 9.1±2.0 IU/mL; non-CAD, 11.7±2.6 IU/mL). Both groups also showed similar significant decreases in PAI-1 activity with exercise (P<.05) and no differences in postexercise PAI-1 activity (CAD, 13.2±2.5 AU/mL; non-CAD, 10.4±3.6 AU/mL). Significantly higher resting TPA antigen levels were seen in CAD (14.8 ng/mL) than non-CAD (10.2 ng/mL) subjects (P<.05), but neither group showed significant changes with exercise (CAD, 12.9 ng/mL; non-CAD, 11.8 ng/mL). Resting PAI-1 antigen was similar in the two groups (CAD, 71.4 ng/mL; non-CAD, 74.2 ng/mL) and did not significantly change with exercise (CAD, 77.9 ng/mL; non-CAD, 72.3 ng/mL). O2max was positively correlated with postexercise TPA activity (r=.52, P<.05) and negatively correlated with resting TPA antigen (r=-.43, P<.05). Resting TPA antigen was also directly correlated with body mass index (r=.63, P<.05). The finding that functional fibrinolytic activity was not different in physically active men with and without CAD contrasts with previous reports. This suggests that matching subjects on the bases of age and habitual physical activity status and controlling exercise intensity are important factors to consider when evaluating fibrinolytic potential.


Key Words: plasminogen activator inhibitor • coronary artery disease • tissue-type plasminogen activator




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
L. M. Szymanski, C. M. Kessler, and B. Fernhall
Relationship of physical fitness, hormone replacement therapy, and hemostatic risk factors in postmenopausal women
J Appl Physiol, April 1, 2005; 98(4): 1341 - 1348.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. W. Lee and G. Y. H. Lip
Effects of Lifestyle on Hemostasis, Fibrinolysis, and Platelet Reactivity: A Systematic Review
Arch Intern Med, October 27, 2003; 163(19): 2368 - 2392.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. G. Wannamethee, G. D.O. Lowe, P. H. Whincup, A. Rumley, M. Walker, and L. Lennon
Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men
Circulation, April 16, 2002; 105(15): 1785 - 1790.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Cesari and G. P. Rossi
Plasminogen Activator Inhibitor Type 1 in Ischemic Cardiomyopathy
Arterioscler Thromb Vasc Biol, June 1, 1999; 19(6): 1378 - 1386.
[Full Text] [PDF]